A medical research institute reports a stake above 5% in Stepan (SCL).
Stowers Institute for Medical Research, along with American Century Investment Management, Inc. and American Century Companies, Inc., has reported a beneficial ownership of 5.4% in Stepan Company (SCL), totaling 1,217,347 shares each, as of September 30, 2026. American Century ETF Trust also reported a 5.1% stake with 1,157,812 shares. These disclosures were made in a Schedule 13G filing with the SEC, indicating passive investment purposes.
Reliance leads materials stocks with biggest Q3 earnings surprise
As the third-quarter earnings season concludes, several materials companies have reported earnings-per-share exceeding Wall Street expectations. Reliance, Inc. led the pack with an EPS surprise of $1.19, significantly outperforming other companies like Alcoa Corporation and Quaker Chemical Corporation. This performance highlights areas of strength within the materials sector despite divergent conditions in global commodity markets.
Some Investors May Be Willing To Look Past Stepan's (NYSE:SCL) Soft Earnings
Stepan Company (NYSE:SCL) recently reported soft profit numbers, yet the market reacted positively. This suggests investors are looking beyond statutory profit figures, possibly recognizing that a US$66m expense from unusual items may not be a recurring issue. Despite a fall in earnings per share over the last year, the underlying earnings potential is believed to be stronger than the reported profit suggests.
Form 4 Stepan Comp: Andrea Jean Barry (SVP & CHRO) For: 9 November
This article reports on a Form 4 filing for Stepan Company, detailing the transaction activity of Andrea Jean Barry, SVP & CHRO, on November 9. Form 4 filings are regulatory documents used to disclose changes in beneficial ownership of securities by company insiders. The filing indicates transactions related to Stepan Company (SCL).
114 shares are withheld for vesting taxes at Stepan (SCL).
Andrea Jean Barry, SVP & CHRO at Stepan Company (SCL), had 386 restricted stock units (RSUs) settled in common shares on November 9, 2026. The RSUs vest ratably over three years. On November 10, 2026, 114 common shares were withheld at $67.8950 per share to cover tax liabilities associated with the RSU vesting.
A stock award correction at Stepan (SCL) leaves 50 shares withheld for taxes unchanged.
Stepan Co (SCL) filed an amended Form 4 to correct a previous insider trading report for SVP Robin Joseph Weitkamp. The correction updates the number of restricted stock units (RSUs) disposed of and common shares acquired from 90 to 140 each. The original report's detail of 50 common shares withheld to cover tax liability remains accurate and unchanged.
Form 4 Stepan Comp: F. Quinn Stepan Jr (Director) For: 3 November
The article reports a Form 4 filing for Stepan Company, detailing transactions made by F. Quinn Stepan Jr, a Director, on November 3. This financial filing indicates insider activity, which can be of interest to investors tracking company management's stock movements. The stock symbol SCL is mentioned with a -3.96% change.
Logistics Property Company snags Joliet property for $29M
Logistics Property Company (LPC) has acquired a 74-acre property in Joliet for $28.5 million, planning a 1.3 million square foot distribution center near major intermodal rail terminals. The Chicago-based developer aims to leverage the site's proximity to the BNSF Railway and Union Pacific intermodal terminals, which form the world's largest inland port. This acquisition follows other recent industrial market activities by LPC, including an expansion plan in Schaumburg and the sale of a vertical warehouse to Amazon at a loss.
Stepan’s Shares Rally As Its Chemical Business Recovers
Stepan, a chemical manufacturer, saw its shares rally significantly, outperforming the S&P 500, due to a strong Q3 2026 performance with sales up 17% and adjusted earnings nearly doubling. This recovery was driven by volume growth across all three segments and cost-cutting initiatives. While the company shows promising signs of a turnaround, concerns remain regarding weak trailing margins, elevated debt, and the long-term sustainability of profit growth.
Stepan Reports Third Quarter 2026 Results
Stepan Company reported significantly improved third-quarter 2026 results, with reported net income up 64% and adjusted net income up 98% year-over-year. The growth was driven by improved performance across all three segments: Surfactants, Polymers, and Specialty Products, alongside global volume growth, margin recovery, and savings from Project Catalyst. Despite ongoing market uncertainties, the company expects to deliver full-year Adjusted EBITDA growth, positive free cash flow, and continued balance sheet de-leveraging in 2026.
Press Release: Stepan Increases Quarterly Cash Dividend, Marking the 59th Consecutive Year of Increases
Stepan Company announced a 10.4% increase in its quarterly cash dividend to $0.415 per share, payable on December 13, 2024. This marks the 59th consecutive year the company has increased its dividend, demonstrating a consistent commitment to returning value to shareholders. The dividend is for shareholders of record as of November 29, 2024.
Press Release: Stepan Increases Quarterly Cash Dividend, Marking the 59th Consecutive Year of Increases
Stepan Company announced its Board of Directors declared a quarterly cash dividend of $0.375 per share on common stock, a 12% increase from the previous dividend. This marks the 59th consecutive year the company has increased its dividend. The dividend is payable on December 13, 2026, to shareholders of record as of November 29, 2026.
Stepan Co.: Q3 Earnings Snapshot
Stepan Co. (SCL) reported net income of $17.8 million in its third quarter, translating to a profit of 78 cents per share. After adjusting for non-recurring and restructuring costs, the company's earnings were 94 cents per share. The specialty chemicals company posted revenue of $468.2 million for the period.
Stepan Just Raised Its Dividend for the 59th Straight Year. Most Investors Have Never Heard of It
Stepan Company (SCL) has raised its quarterly dividend for the 59th consecutive year, reaching $0.405 per share, cementing its status as a Dividend King. Despite its small size and being largely unknown to many investors, Stepan is a key ingredient supplier for surfactants and polymers used in various household and industrial products. The company has demonstrated resilience during economic downturns, maintaining profit growth and dividend increases even when revenue declined, though recent cash flow and raw material price swings present some risks.
Stepan Q3 2026 Earnings Call Transcript
Stepan Company reported strong third-quarter 2026 financial results, with Adjusted EBITDA increasing 18% to $66 million and adjusted earnings per share nearly doubling to $0.94. The growth was driven by 7% organic volume growth across all segments, margin recovery, and savings from Project Catalyst, which is ahead of schedule. The company also improved its net leverage ratio to 2.4 times after selling land for $28.5 million and increased its quarterly dividend for the 59th consecutive year.
Stepan Company (SCL) Q3 Adj. EBITDA $66.3M, +18% YoY; Net Sales +17%
Stepan Company (SCL) reported strong Q3 2026 results with adjusted EBITDA of $66.3 million, an 18% increase year-over-year, driven by a 17% rise in net sales due to higher prices and a 3% volume increase. The Surfactant segment's adjusted EBITDA grew significantly by 27%, while Specialty Products and Polymers also saw single-digit growth. The company also generated approximately $8.2 million in free cash flow after capital expenditures and provided a positive outlook for FY26 adjusted EBITDA growth.
Stepan Company Q3 2026 Earnings Call Is Live
Stepan Company's Q3 2026 earnings call has commenced, where executives will discuss financial results and answer questions from analysts. This call is a critical opportunity for investors following SCL to understand the company's performance, future outlook, and potential news that could impact market sentiment. Management commentary during these calls often influences market movements as much as the official earnings release.
Stepan Increases Quarterly Cash Dividend, Marking the 59th Consecutive Year of Increases
Stepan Company announced that its Board of Directors has declared a quarterly cash dividend of $0.405 per share, payable on December 15, 2026, to stockholders of record on December 1, 2026. This increase of $0.010 per share marks the 59th consecutive year the company has raised its cash dividend. Stepan is a major manufacturer of specialty and intermediate chemicals used across various industries, including cleaning, agriculture, oilfield solutions, and thermal insulation.
Stepan Co. (SCL) Tops Q3 EPS by 21c
Stepan Co. (NYSE: SCL) announced strong Q3 results, reporting earnings per share of $0.94, significantly exceeding analyst estimates of $0.73 by $0.21. The company's revenue for the quarter also surpassed expectations, reaching $692.15 million against a consensus estimate of $634.3 million.
Stepan Company (SCL) Raises Quarterly Dividend to $0.405
Stepan Company (SCL) has increased its quarterly cash dividend by $0.010 to $0.405 per share, marking its 59th consecutive year of dividend increases. The dividend is payable on December 15, 2026, to shareholders of record as of December 1, 2026. This move reinforces the company's long-running dividend growth pattern and signals confidence in its financial stability.
Stepan Q3 2026 slides: EPS doubles on volume growth, restructuring
Stepan Company reported a strong Q3 2026, with adjusted EPS nearly doubling year-over-year to $0.94, driven by 7% organic volume growth across all segments and accelerating savings from its Project Catalyst restructuring initiative. The company's shares rose over 2% following the announcement, extending a 40% year-to-date rally, as results surpassed Wall Street expectations for both earnings and revenue. Project Catalyst is on track to exceed its 2026 savings target, and the company is focused on continued deleveraging and strategic growth in key markets.
Stepan Q3 2026 slides show 18% EBITDA growth, Catalyst savings surge
Stepan Company reported strong Q3 2026 results, with adjusted EBITDA growing 18% year-over-year to $66.3 million, driven by organic volume growth and margin recovery. The company's Project Catalyst restructuring initiative is exceeding its savings targets, contributing to a significant increase in adjusted net income and EPS. Stepan also outlined a strategic framework focused on customer-focused solutions, diversification, operational excellence, and financial strength, leading to a 51.6% rally in its stock over the past year.
Stepan Company Announces $0.405 Quarterly Dividend, Extending 59-Year Consecutive Increase
Stepan Company has declared a quarterly cash dividend of $0.405 per share, payable on December 15, 2026, to shareholders of record as of December 1, 2026. This dividend represents a $0.010 increase per share for Q4 2026 and marks the 59th consecutive year the company has raised its cash dividend. Stepan Company, a manufacturer of specialty and intermediate chemicals, emphasizes its consistent commitment to shareholder returns.
Stepan Company Estimates – NYSE:SCL
This page on TradingView provides financial data and analyst estimates for Stepan Company (NYSE: SCL). It allows users to explore reported financial data across income statements, balance sheets, cash flow statements, and valuation metrics, comparing actual results with average, high, and low estimates, and visualizing trends over time. The content explicitly states that it is not investment advice.
Argus cuts target to USD 65.00 for Stepan stock
Argus has lowered its target for Stepan Company (SCL) to USD 65.00, according to a research note dated October 14, 2026. The company is set to release its third-quarter 2026 results on October 28, which will provide further insight into its financial performance after a strong second quarter. Investors will be watching this report to assess the company's operational execution against the revised target.
Stepan stock has a USD 85.00 target 37.03 percent above price
Stepan stock has an analyst target of USD 85.00, which is 37.03% above its current price of USD 62.03 as of October 16, 2026. The company reported a 15% year-over-year increase in second-quarter revenue, reaching USD 684.11 million, and exceeded earnings per share estimates. Despite a negative P/E ratio, the stock's valuation and recent growth suggest investors should closely monitor upcoming earnings.
Stepan sets October 28, 2026 for results. Stepan stock yields 3.00 percent
Stepan Company (SCL) has scheduled its third-quarter results for October 28, 2026. The stock was trading at EUR 55.25 on October 15, 2026, with a year-to-date gain of 31.17 percent and a market capitalization of USD 1.4 billion. Investors are keenly awaiting the upcoming earnings report to assess the company's financial performance in specialty chemicals.
DIMENSIONAL FUND ADVISORS LP Adds Stepan Co (SCL) Shares -- Stock Looks 12% Undervalued on GF Value
Dimensional Fund Advisors LP has increased its stake in Stepan Co (SCL) by purchasing 66,990 additional shares, bringing its total ownership to 5.20%. Stepan Co, a specialty chemicals manufacturer, is currently valued as "Modestly Undervalued" by GuruFocus, with a GF Score of 81 despite facing negative profitability and growth trends. This move reflects Dimensional's systematic investment approach and continued confidence in Stepan Co's long-term fundamentals.
Stepan to Announce Third Quarter 2026 Results on October 28, 2026
Stepan Company (SCL) will release its third quarter 2026 earnings results on Wednesday, October 28, 2026, at approximately 7:00 a.m. ET. The company will also host a conference call on the same day at 9:00 a.m. ET to discuss its financial and operational performance, with details for phone and webcast access provided. Stepan is a major manufacturer of specialty and intermediate chemicals, including surfactants and polyurethane polyols, with its common stock traded on the New York Stock Exchange.
Stepan Company to release Q3 2026 earnings on Oct 28 with a conference call at 9 a.m. ET.
Stepan Company announced it will release its third quarter 2026 earnings on October 28, 2026, at 7 a.m. ET, followed by a conference call at 9 a.m. ET to discuss financial performance. This report is crucial for investors as Stepan is a major chemical manufacturer, offering insights into its business health and future outlook. The article also provides a market snapshot for the Basic Materials sector as of October 7, 2026.
Stepan to Announce Third Quarter 2026 Results on October 28, 2026
Stepan Company (NYSE: SCL) will release its third-quarter 2026 earnings results on Wednesday, October 28, 2026, at approximately 7:00 a.m. ET. The company will also host a conference call on the same day at 9:00 a.m. ET to discuss its financial and operational performance, which will be accessible via phone and webcast. Stepan Company is a major manufacturer of specialty and intermediate chemicals used across various industries, including surfactants for cleaning and agricultural products, and polyurethane polyols for thermal insulation.
Stepan to Announce Third Quarter 2026 Results on October 28, 2026
Stepan Company announced it will release its third quarter 2026 financial results on October 28, 2026, before the stock market opens. The company will also host a conference call and webcast on the same day to discuss these results, which will include a question and answer session.
One adviser reports a passive stake above 5% in Stepan (SCL) across multiple funds.
Dimensional Fund Advisors LP has reported a 5.2% passive stake in Stepan Co (SCL) through various funds it advises, sub-advises, or manages, as of September 30, 2026. The filing indicates that Dimensional disclaims beneficial ownership, with the shares actually owned by the Funds. No single fund holds more than 5% of Stepan's class of securities.
Stepan to Announce Third Quarter 2026 Results on October 28, 2026
Stepan Company (NYSE: SCL) will release its third-quarter 2026 earnings on Wednesday, October 28, 2026, at approximately 7:00 a.m. ET. The company will also host a conference call on the same day at 9:00 a.m. ET to discuss its financial and operational performance. Investors can access supporting slides and the webcast replay on Stepan's investor relations website.
Stepan to issue Q3 2026 earnings results on Oct. 28
Stepan (NYSE: SCL) is scheduled to release its third-quarter 2026 earnings results on October 28, 2026, at approximately 7:00 a.m. ET. The company will host a conference call on the same day at 9:00 a.m. ET to discuss financial and operational performance, led by CEO Luis E. Rojo and CFO Ruben Velasquez. A webcast replay will be available on Stepan's website shortly after the call.
Stepan to Announce Third Quarter 2026 Results on October 28, 2026
Stepan Company (NYSE: SCL) will release its third-quarter 2026 earnings results on Wednesday, October 28, 2026, at approximately 7:00 a.m. ET. The company will also host a conference call on the same day at 9:00 a.m. ET to discuss its financial and operational performance, led by CEO Luis E. Rojo and CFO Ruben Velasquez. Investors can access supporting slides and the webcast replay on the company's investor relations website.
Zacks upgrades Stepan Company stock to Strong Buy
Zacks Research has upgraded Stepan Company (SCL) stock from "hold" to "strong buy" following strong second-quarter 2026 earnings that exceeded analyst consensus for both earnings per share and revenue. The company reported adjusted earnings per share of USD 1.18 and revenue of USD 684.11 million. Despite the upgrade, the stock's euro quote remained unchanged on October 6, 2026, though Seaport Research Partners maintains an USD 85.00 price target.
Stepan stock reports 15 percent revenue growth in Q2 2026
Stepan Company reported a 15% revenue growth in Q2 2026, reaching $684.11 million, with adjusted EPS of $1.18 significantly beating analyst estimates. This positive earnings report has led to an analyst upgrade to "Strong Buy" and a price target of $85.00, suggesting substantial upside from its current trading price of $63.00. The company's market capitalization stands at $1.4 billion, with its stock trading above its 200-day moving average.
Best Momentum Stock to Buy for September 30th
Zacks Investment Research highlights Stepan (SCL) and AC Immune (ACIU) as top momentum stocks to consider. Both companies have a Zacks Rank #1 (Strong Buy) and have shown significant earnings estimate increases and share price gains over the last three months, outperforming the S&P 500. These stocks are presented for investors seeking strong momentum characteristics.
Best Momentum Stock to Buy for September 30th
This article identifies two top momentum stocks, Stepan (SCL) and AC Immune (ACIU), for investors to consider on September 30th. Both companies hold a Zacks Rank #1 (Strong Buy) and have shown significant earnings estimate revisions and stock price gains over the last three months, outperforming the S&P 500. The article highlights their strong momentum characteristics based on Zacks' scoring system.
Best Momentum Stock to Buy for September 30th
This article highlights two momentum stocks, Stepan (SCL) and AC Immune (ACIU), as strong buys for September 30th. Both companies have a Zacks Rank #1 (Strong Buy) and have shown significant earnings estimate revisions and stock price gains compared to the S&P 500.
Stepan Company rebounds with strong margin and sales growth, targeting 11.2% upside by 2028.
Stepan Company is showing strong recovery with significant margin and sales growth, particularly in North America. This is attributed to effective cost-saving strategies and robust demand in key sectors like data center construction. Analysts rate the stock as a Buy, projecting an 11.2% upside by 2028 due to its sustainable dividends, attractive valuation, and strategic growth initiatives.
Stepan lands $500M credit line, lifting borrowing capacity by $50M
Stepan Company has secured a new five-year, $500 million credit agreement, replacing a previous $450 million package. This deal, led by JPMorgan Chase Bank and Bank of America, increases the specialty chemicals maker's borrowing capacity by $50 million and extends its debt maturities. The new facility includes a $350 million multicurrency revolving credit line and a $150 million delayed draw term loan, providing liquidity for working capital, acquisitions, and general corporate purposes, with an option to expand to $750 million.
Stepan Company (SCL) Stock Price, News, Quote & History
This article provides a detailed overview of Stepan Company (SCL) stock, including its current price, historical performance, key financial metrics, and analyst insights. It covers the company's business segments—Surfactants, Polymers, and Specialty Products—and its global operations in specialty and intermediate chemicals. The report also includes recent news, performance over various periods, earnings trends, and valuation measures.
Stepan Company stock holds at USD 61.81 as Nasdaq gains
Stepan Company's stock closed at USD 61.81 on September 22, 2026, experiencing a slight decline of 0.11% while the broader Nasdaq Composite gained 2.26% to reach 27,122.09 points. This performance indicates that the technology-led market strength did not translate to Stepan Company, which operates in specialty chemicals. The article highlights the discrepancy between the stock's performance and its reported 52-week range, emphasizing the need for periodized company updates to assess earnings momentum.
Stepan Company stock edges lower after recent gains as investors watch latest results
Stepan Company's stock saw a slight decline after significant gains over the past year, closing at USD 61.78 on September 18, 2026. While revenue increased by approximately 4%, diluted earnings per share decreased by nearly 14%, raising concerns about margin pressure among investors. The company's market capitalization is in the mid-single-digit billion-dollar range, and investors are closely monitoring future earnings reports for signs of consistent earnings expansion.
Empowered Funds takes new $4.95M stake in chemical maker Stepan
Empowered Funds LLC has acquired a new stake of 88,869 shares, valued at $4.95 million, in Stepan Company, a global manufacturer of specialty chemicals. This investment follows Stepan's strong second-quarter earnings, where it surpassed revenue and EPS expectations. The move by Empowered Funds aligns with other institutional buyers increasing their holdings, despite mixed analyst sentiment, signaling renewed interest in the company.
Stepan Eyes Margin Recovery as Catalyst Targets $100M in Savings
Stepan (NYSE:SCL) is in the early stages of a margin recovery, driven by growth in higher-margin product areas, cost reductions through Project Catalyst, and broader volume gains. The company aims for $100 million in savings by 2027 through footprint optimization and workforce reductions, while prioritizing segments like crop productivity and oilfield chemicals. Stepan also plans to reduce leverage and achieve positive cash generation for the year.
Stepan Company VP Shawn Lisle Executes RSU Vesting and Tax Share Withholding on August 26, 2026
Shawn G. Lisle, VP, General Counsel, and Secretary of Stepan Company (NYSE:SCL), completed the settlement of 1,154 restricted stock units (RSUs) on August 26, 2026. He also executed share withholding for tax purposes, resulting in 339 shares being withheld. Following these transactions, Lisle directly holds 840.544 common shares and beneficially owns 2,308 outstanding RSUs that will vest evenly over three years.
Does Stepan (SCL) Balancing Quarterly Profits and Dividends Clarify Its Long‑Term Strategy?
Stepan Company recently reported mixed financial results, showing stronger Q2 2026 earnings but a six-month net loss, while maintaining its quarterly dividend. The article discusses how these results impact Stepan's investment outlook, emphasizing the need for the company to convert its specialty chemicals assets into consistent earnings and cash flow. It also highlights the differing fair value estimates for SCL among investors and suggests further research into the company's financial health.